Ultra-high resolution and ultra-sensitive fluorescence methods for objective sub-cellular
diagnosis of early disease and disease progression in breast and prostate cancer.
09:00-09:10 Introduction and overview of the aims of the FLUODIAMON project.
(J. Widengren, KTH Stockholm)
09:10-10:00 Breast and prostate cancer – a clinical orientation.
(L. Löfgren, KI Stockholm; H. Jorulf, Uppsala Univ.)
10:00-10:20 Diagnostic sampling by Fine-Needle-Aspiration –
needle development and anti-seeding procedures.
(G. Auer, KI; H. Wiksell, NeoDynamics AB)
10:20-10:50 The Human Protein Atlas project.
(S. Hober, KTH)
10:50-11:05 Affinity molecules for subcellular diagnostics.
(P.Å. Nygren; A. Karlström-Eriksson, KTH;
S. van der Maarel, Leiden Univ. Medical Center, Netherlands)
11:05-11:20 Coffee break
11:20-11:50 Stimulated Emission Depletion (STED) imaging.
(S.W. Hell, Max Plank Inst., Göttingen, Germany)
11:50-12:10 Multiparameter Fluorescence Detection imaging (MFDi).
(C.A.M. Seidel, Heinrich Heine Univ. Düsseldorf, Germany)
12:10-12:30 Image analysis.
(V. Rantanen, Univ. of Helsinki)
12:30-12:55 First images on cultured cells and FNA samples within the FLUODIAMON project.
12:55-13:00 Concluding remarks.
This workshop is organized by the FLUODIAMON project and supported by funds from the
European Union 7th Framework Programme.